Eagle Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.2M | Buy |
8,119
+1,440
| +22% | +$744K | 0.02% | 405 |
|
|
2024
Q2 | $3.15M | Buy |
6,679
+814
| +14% | +$384K | 0.02% | 434 |
|
|
2024
Q1 | $2.47M | Sell |
5,865
-243
| -4% | -$102K | 0.01% | 460 |
|
|
2023
Q4 | $2.49M | Sell |
6,108
-977
| -14% | -$398K | 0.01% | 435 |
|
|
2023
Q3 | $2.46M | Sell |
7,085
-280
| -4% | -$97.4K | 0.01% | 418 |
|
|
2023
Q2 | $2.59M | Buy |
7,365
+643
| +10% | +$226K | 0.01% | 423 |
|
|
2023
Q1 | $2.12M | Buy |
+6,722
| New | +$2.12M | 0.01% | 435 |
|
|
2016
Q2 | – | Sell |
-98,933
| Closed | -$7.86M | – | 656 |
|
|
2016
Q1 | $7.86M | Buy |
98,933
+7,634
| +8% | +$607K | 0.05% | 347 |
|
|
2015
Q4 | $11.5M | Buy |
91,299
+9,494
| +12% | +$1.19M | 0.08% | 316 |
|
|
2015
Q3 | $8.52M | Buy |
81,805
+10,021
| +14% | +$1.04M | 0.06% | 345 |
|
|
2015
Q2 | $8.86M | Buy |
71,784
+3,067
| +4% | +$379K | 0.05% | 348 |
|
|
2015
Q1 | $8.11M | Buy |
68,717
+213
| +0.3% | +$25.1K | 0.05% | 362 |
|
|
2014
Q4 | $8.14M | Buy |
68,504
+2,208
| +3% | +$262K | 0.05% | 353 |
|
|
2014
Q3 | $7.45M | Buy |
+66,296
| New | +$7.45M | 0.04% | 371 |
|
|
2013
Q4 | – | Sell |
-353,623
| Closed | -$26.9M | – | 662 |
|
|
2013
Q3 | $26.9M | Buy |
353,623
+408
| +0.1% | +$31K | 0.13% | 202 |
|
|
2013
Q2 | $28.3M | Buy |
+353,215
| New | +$28.3M | 0.19% | 171 |
|